COLOPLAST-B (CBHD.DE) Fundamental Analysis & Valuation

FRA:CBHD • DK0060448595

62.68 EUR
+2.22 (+3.67%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This CBHD.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CBHD gets a fundamental rating of 5 out of 10. We evaluated CBHD against 63 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are some minor concerns on its financial health. CBHD has a correct valuation and a medium growth rate. Finally CBHD also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. CBHD.DE Profitability Analysis

1.1 Basic Checks

  • In the past year CBHD was profitable.
  • CBHD had a positive operating cash flow in the past year.
  • In the past 5 years CBHD has always been profitable.
  • In the past 5 years CBHD always reported a positive cash flow from operatings.
CBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFCBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With an excellent Return On Assets value of 8.17%, CBHD belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
  • The Return On Equity of CBHD (28.90%) is better than 96.83% of its industry peers.
  • CBHD has a better Return On Invested Capital (12.85%) than 88.89% of its industry peers.
  • CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 9.88%.
Industry RankSector Rank
ROA 8.17%
ROE 28.9%
ROIC 12.85%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
CBHD.DE Yearly ROA, ROE, ROICCBHD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 14.30%, CBHD belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
  • CBHD's Profit Margin has declined in the last couple of years.
  • CBHD's Operating Margin of 27.28% is amongst the best of the industry. CBHD outperforms 95.24% of its industry peers.
  • CBHD's Operating Margin has declined in the last couple of years.
  • CBHD's Gross Margin of 67.87% is fine compared to the rest of the industry. CBHD outperforms 73.02% of its industry peers.
  • In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
Industry RankSector Rank
OM 27.28%
PM (TTM) 14.3%
GM 67.87%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
CBHD.DE Yearly Profit, Operating, Gross MarginsCBHD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CBHD.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
  • The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CBHD has more shares outstanding
  • Compared to 1 year ago, CBHD has an improved debt to assets ratio.
CBHD.DE Yearly Shares OutstandingCBHD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CBHD.DE Yearly Total Debt VS Total AssetsCBHD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.20 indicates that CBHD is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.20, CBHD is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of CBHD is 4.70, which is a neutral value as it means it would take CBHD, 4.70 years of fcf income to pay off all of its debts.
  • CBHD has a Debt to FCF ratio (4.70) which is in line with its industry peers.
  • CBHD has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
  • CBHD's Debt to Equity ratio of 1.55 is on the low side compared to the rest of the industry. CBHD is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 4.7
Altman-Z 3.2
ROIC/WACC2.18
WACC5.89%
CBHD.DE Yearly LT Debt VS Equity VS FCFCBHD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that CBHD should not have too much problems paying its short term obligations.
  • CBHD's Current ratio of 1.30 is on the low side compared to the rest of the industry. CBHD is outperformed by 60.32% of its industry peers.
  • CBHD has a Quick Ratio of 1.30. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.81, CBHD is not doing good in the industry: 68.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.81
CBHD.DE Yearly Current Assets VS Current LiabilitesCBHD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CBHD.DE Growth Analysis

3.1 Past

  • CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.16%.
  • The Earnings Per Share has been decreasing by -2.02% on average over the past years.
  • The Revenue has been growing slightly by 1.61% in the past year.
  • Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%

3.2 Future

  • CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.61% yearly.
  • CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.37% yearly.
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y15.61%
Revenue Next Year3.82%
Revenue Next 2Y5.46%
Revenue Next 3Y5.81%
Revenue Next 5Y6.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBHD.DE Yearly Revenue VS EstimatesCBHD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
CBHD.DE Yearly EPS VS EstimatesCBHD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

6

4. CBHD.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.58 indicates a rather expensive valuation of CBHD.
  • Based on the Price/Earnings ratio, CBHD is valued a bit cheaper than the industry average as 63.49% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, CBHD is valued at the same level.
  • The Price/Forward Earnings ratio is 16.29, which indicates a correct valuation of CBHD.
  • Based on the Price/Forward Earnings ratio, CBHD is valued a bit cheaper than 69.84% of the companies in the same industry.
  • CBHD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 24.58
Fwd PE 16.29
CBHD.DE Price Earnings VS Forward Price EarningsCBHD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CBHD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 65.08% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD indicates a rather cheap valuation: CBHD is cheaper than 80.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.44
EV/EBITDA 13.1
CBHD.DE Per share dataCBHD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CBHD may justify a higher PE ratio.
  • CBHD's earnings are expected to grow with 21.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y27.22%
EPS Next 3Y21.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. CBHD.DE Dividend Analysis

5.1 Amount

  • CBHD has a Yearly Dividend Yield of 4.78%, which is a nice return.
  • CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.06. CBHD pays more dividend than 98.41% of the companies in the same industry.
  • CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.78%

5.2 History

  • The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
CBHD.DE Yearly Dividends per shareCBHD.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

5.3 Sustainability

  • 129.96% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
  • CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP129.96%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
CBHD.DE Yearly Income VS Free CF VS DividendCBHD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
CBHD.DE Dividend Payout.CBHD.DE Dividend Payout, showing the Payout Ratio.CBHD.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CBHD.DE Fundamentals: All Metrics, Ratios and Statistics

COLOPLAST-B

FRA:CBHD (3/6/2026, 7:00:00 PM)

62.68

+2.22 (+3.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06
Earnings (Next)05-12
Inst Owners28.86%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap13.18B
Revenue(TTM)27.89B
Net Income(TTM)3.99B
Analysts69.63
Price Target77.93 (24.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.78%
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP129.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.23%
Min EPS beat(2)-26.06%
Max EPS beat(2)1.6%
EPS beat(4)1
Avg EPS beat(4)-15.95%
Min EPS beat(4)-26.06%
Max EPS beat(4)1.6%
EPS beat(8)1
Avg EPS beat(8)-11.35%
EPS beat(12)1
Avg EPS beat(12)-9.84%
EPS beat(16)2
Avg EPS beat(16)-9.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.24%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.49%
Revenue beat(12)1
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)-14.61%
PT rev (3m)-16.81%
EPS NQ rev (1m)-7.76%
EPS NQ rev (3m)-7.8%
EPS NY rev (1m)0%
EPS NY rev (3m)0.83%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)1.23%
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-1.7%
Valuation
Industry RankSector Rank
PE 24.58
Fwd PE 16.29
P/S 3.53
P/FCF 18.44
P/OCF 14.33
P/B 7.13
P/tB N/A
EV/EBITDA 13.1
EPS(TTM)2.55
EY4.07%
EPS(NY)3.85
Fwd EY6.14%
FCF(TTM)3.4
FCFY5.42%
OCF(TTM)4.37
OCFY6.98%
SpS17.76
BVpS8.79
TBVpS-10.42
PEG (NY)0.52
PEG (5Y)N/A
Graham Number22.46
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 28.9%
ROCE 18.62%
ROIC 12.85%
ROICexc 13.21%
ROICexgc 54.89%
OM 27.28%
PM (TTM) 14.3%
GM 67.87%
FCFM 19.14%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-ScoreN/A
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 4.7
Debt/EBITDA 2.36
Cap/Depr 104.29%
Cap/Sales 5.5%
Interest Coverage 12.72
Cash Conversion 75.69%
Profit Quality 133.82%
Current Ratio 1.3
Quick Ratio 0.81
Altman-Z 3.2
F-ScoreN/A
WACC5.89%
ROIC/WACC2.18
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y15.61%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%
Revenue Next Year3.82%
Revenue Next 2Y5.46%
Revenue Next 3Y5.81%
Revenue Next 5Y6.37%
EBIT growth 1Y3.15%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year25.07%
EBIT Next 3Y13.25%
EBIT Next 5Y11.23%
FCF growth 1Y24.69%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y24.41%
OCF growth 3Y9.24%
OCF growth 5Y6.9%

COLOPLAST-B / CBHD.DE FAQ

What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.


Can you provide the valuation status for COLOPLAST-B?

ChartMill assigns a valuation rating of 6 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for COLOPLAST-B?

COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.


How financially healthy is COLOPLAST-B?

The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.


What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?

The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.9% in the next year.